Literature DB >> 23585144

Trends in immediate breast reconstruction across insurance groups after enactment of breast cancer legislation.

Rachel L Yang1, Andrew S Newman, Ines C Lin, Caroline E Reinke, Giorgos C Karakousis, Brian J Czerniecki, Liza C Wu, Rachel R Kelz.   

Abstract

BACKGROUND: To improve access to breast reconstruction for mastectomy patients, the United States enacted the Women's Health and Cancer Rights Act in January of 1999. The objective of the current study was to evaluate the impact of this legislation on patients with different insurance plans.
METHODS: Women aged ≥18 years who underwent mastectomy for cancer were identified in the Nationwide Inpatient Sample database (2000-2009) and were classified according to their immediate breast reconstruction (IBR) status. Trends in rates of IBR were described for each insurance category. Multivariable logistic regression analysis with adjustment for age, race, estimated household income, and Elixhauser comorbidity index was performed to evaluate the relation between insurance status and IBR.
RESULTS: In total, 168,236 patients were identified who underwent a mastectomy during the study interval. Across the 10-year study period, rates of IBR increased 4.2-fold in Medicaid patients, 2.9-fold in Medicare patients, 2.6-fold in privately insured patients, and 2.1-fold in self-pay patients (P < .01). However, after adjustment for confounders, women without private insurance were less likely to undergo IBR compared with women who had private insurance (Medicaid: odds ratio [OR], 0.34; 95% confidence interval [CI], 0.32-0.37; Medicare: OR, 0.53; 95% CI, 0.49-0.58; self-pay: OR, 0.43; 95% CI, 0.37-0.50; other types of nonprivate insurance: OR, 0.64, 95% CI, 0.56-0.73).
CONCLUSIONS: After the enactment of policy designed to improve access to IBR, Medicaid and Medicare patients experienced the greatest relative increase in rates of IBR. Although policy changes had the most impact on traditionally underserved populations, disparities still exist. Future studies should endeavor to understand why such disparities have persisted.
Copyright © 2013 American Cancer Society.

Entities:  

Mesh:

Year:  2013        PMID: 23585144     DOI: 10.1002/cncr.28050

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  35 in total

1.  Decline in Racial Disparities in Postmastectomy Breast Reconstruction: A Surveillance, Epidemiology, and End Results Analysis from 1998 to 2014.

Authors:  Amanda R Sergesketter; Samantha M Thomas; Whitney O Lane; Jonah P Orr; Ronnie L Shammas; Oluwadamilola M Fayanju; Rachel A Greenup; Scott T Hollenbeck
Journal:  Plast Reconstr Surg       Date:  2019-06       Impact factor: 4.730

2.  Influence of Patient and Hospital Characteristics on the Performance of Direct Reconstruction after Mastectomy.

Authors:  J Hartrampf; L Ansmann; S Wesselmann; M W Beckmann; H Pfaff; C Kowalski
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-12       Impact factor: 2.915

3.  Emerging trends in surgical and adjuvant radiation therapies among women diagnosed with ductal carcinoma in situ.

Authors:  Oyewale O Shiyanbola; Brian L Sprague; John M Hampton; Kim Dittus; Ted A James; Sally Herschorn; Ronald E Gangnon; Donald L Weaver; Amy Trentham-Dietz
Journal:  Cancer       Date:  2016-05-31       Impact factor: 6.860

4.  Factors influencing the decision to pursue immediate breast reconstruction after mastectomy for breast cancer.

Authors:  Mariska Weenk; Philipp Wunschel; Erwin Heine; Luc J Strobbe
Journal:  Gland Surg       Date:  2017-02

5.  Achieving consistent and equitable access to post mastectomy breast reconstruction.

Authors:  Anne C O'Neill
Journal:  Gland Surg       Date:  2020-08

6.  Health insurance coverage and racial disparities in breast reconstruction after mastectomy.

Authors:  Tetyana P Shippee; Katy B Kozhimannil; Kathleen Rowan; Beth A Virnig
Journal:  Womens Health Issues       Date:  2014 May-Jun

7.  Breast Conservation After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Surgical Results From the BrighTNess Randomized Clinical Trial.

Authors:  Mehra Golshan; Sibylle Loibl; Stephanie M Wong; Jens Bodo Houber; Joyce O'Shaughnessy; Hope S Rugo; Norman Wolmark; Mark D McKee; David Maag; Danielle M Sullivan; Otto Metzger-Filho; Gunter Von Minckwitz; Charles E Geyer; William M Sikov; Michael Untch
Journal:  JAMA Surg       Date:  2020-03-18       Impact factor: 14.766

8.  Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States.

Authors:  Reshma Jagsi; Jing Jiang; Adeyiza O Momoh; Amy Alderman; Sharon H Giordano; Thomas A Buchholz; Steven J Kronowitz; Benjamin D Smith
Journal:  J Clin Oncol       Date:  2014-02-18       Impact factor: 44.544

9.  Healthcare Utilization and Costs During the Initial Phase of Care Among Elderly Women With Breast Cancer.

Authors:  Ami Vyas; S Suresh Madhavan; Usha Sambamoorthi; Xiaoyun Lucy Pan; Michael Regier; Hannah Hazard; Sita Kalidindi
Journal:  J Natl Compr Canc Netw       Date:  2017-11       Impact factor: 11.908

10.  Breast reconstruction after mastectomy among Department of Defense beneficiaries by race.

Authors:  Lindsey R Enewold; Katherine A McGlynn; Shelia H Zahm; Jill Poudrier; William F Anderson; Craig D Shriver; Kangmin Zhu
Journal:  Cancer       Date:  2014-06-25       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.